LM-02 Trial Summary

A perioperative, single-arm, multicenter, phase-II academical trial to investigate the efficacy and safety of panitumumab in combination with irinotecan/5-fluorouracil/leucovorin (FOLFIRI) in patients with previously untreated, RAS-wild-type, potentially resectable colorectal cancer liver metastases

Start: 10/2012
Coordinating investigator: Öfner-Velano, Dietmar; Innsbruck
Thaler, Josef; Wels-Grieskirchen
Sample size: 36
(Click to enlarge)
LM-02 Design